Table 3.
Prediabetes progression and regression on changes in physical function from baselinea
Variable | No. of participants | Mean changes | Comparisons using regression analysis |
|||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
Changes in grip strength, kg | ||||||
Prediabetes maintenance | 565 | –2.75±4.84 | Ref | Ref | Ref | |
Prediabetes progression | 251 | –3.47±5.22 | –0.72 (–1.46 to 0.02) | –0.72 (–1.45 to 0.01) | –0.85 (–1.65 to –0.04) | |
Prediabetes regression | 411 | –2.54±5.01 | 0.21 (–0.42 to 0.84) | 0.09 (–0.53 to 0.71) | 0.15 (–0.55 to 0.86) | |
Changes in walking speed, m/sec | ||||||
Prediabetes maintenance | 183 | –0.18±0.23 | Ref | Ref | Ref | |
Prediabetes progression | 69 | –0.18±0.20 | –0.01 (–0.07 to 0.05) | –0.01 (–0.07 to 0.05) | 0.03 (–0.03 to 0.09) | |
Prediabetes regression | 154 | –0.20±0.19 | –0.02 (–0.07 to 0.02) | –0.01 (–0.06 to 0.03) | –0.04 (–0.09 to 0.01) |
Values are presented as mean±standard deviation or change (95% confidence interval). Model 1: without adjustment; Model 2: adjusted for age, sex, and body mass index; Model 3: additionally adjusted for history of smoking and drinking (yes or no), taking physical exercise (yes or no), history of chronic lung disease (with or without), arthritis (with or without), and Alzheimer’s disease (with or without), diastolic blood pressure, glycosylated hemoglobin, total cholesterol/high-density lipoprotein cholesterol, and C-reactive protein, and corresponding physical function at baseline.
The classifications of prediabetes, diabetes, and normoglycemia were defined based on the 2021 American Diabetes Association criteria.